Skip to main content

Table 1 Anthropometric, demographic and clinical data of T2DM with and without CAD compared to normal healthy controls

From: Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease

Variables

Controls (n = 149)

T2DM (n = 155)

T2DM + CAD (n = 147)

Age (Years)

52.01 (0.62)

51.95 (0.53)

57.56 (0.47)**

Sex (male/female)

49/100

57/98

95/52**

BMI (kg/m 2 )

23.84 (0.27)

26.89 (0.31)*

27.49 (0.36)**

SBP (mmHg)

111.54 (1.12)

147.31 (1.76)*

155.46 (1.96)**

DBP (mmHg)

73.11 (0.86)

84.50 (1.01)*

92.26 (1.20)**

Hypertension (%)

-

73.54

93.19

Smokers (%)

3.35

4.51

9.52†

Alcohol consumer (%)

23.80

25.50

32.70

Physical activity (%)

68.70

67.09

56.46†

Diabetes duration (Years)

-

6.09 (0.37)

9.07 (0.62)

Glucose (mg/dL)

89.7 (0.64)

225.9 (6.41)*

192.9 (6.55)**

HbA1c (%)

-

8.94 (0.16)

8.60 (0.17)

Triglyceride (mg/dL)

98.23 (3.68)

221.1 (10.35)*

204.3 (8.70)**

TC (mg/dL)

191.52 (1.80)

237.76 (5.47)*

202.48(4.19)†

LDL-C (mg/dL)

111.31(1.76)

146.65(4.84)*

122.36(3.93)†

HDL-C (mg/dL)

60.17 (1.23)

50.42 (1.27)*

44.59 (0.95)**

VLDL-C (mg/dL)

19.65 (0.73)

45.86 (2.67)*

40.86 (1.74)**

Non-HDL-C (mg/dL)

131.35 (1.95)

182.26 (4.46)*

157.88 (4.09)**

TC/HDL-C

3.4 (0.1)

4.9 (0.2)*

4.8 (0.1)**

Dyslipidemia (%)

-

85.2

100

  1. Data are presented as mean values (SEM), or numbers (n) and percentage of subjects. *p-value < 0.0001 in comparison between controls and T2DM, **p-value < 0.0001 in comparison between controls and T2DM + CAD, †p-value < 0.05 in comparison between controls and T2DM + CAD. BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; HbA1c: hemoglobin A1c; TC: total cholesterol; LDL-C: low density lipoprotein cholesterol; TG: triglyceride; HDL-C: high density lipoprotein cholesterol; VLDL-C: very low density lipoprotein cholesterol.